- Home
- ELWS vs EDSA Comparison
ELWS vs EDSA Comparison
Compare ELWS & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELWS
- EDSA
- Stock Information
- Founded
- ELWS 2018
- EDSA 2015
- Country
- ELWS Japan
- EDSA Canada
- Employees
- ELWS N/A
- EDSA N/A
- Industry
- ELWS
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- ELWS
- EDSA Health Care
- Exchange
- ELWS Nasdaq
- EDSA Nasdaq
- Market Cap
- ELWS 6.2M
- EDSA 6.2M
- IPO Year
- ELWS 2023
- EDSA N/A
- Fundamental
- Price
- ELWS $1.89
- EDSA $2.30
- Analyst Decision
- ELWS
- EDSA Strong Buy
- Analyst Count
- ELWS 0
- EDSA 1
- Target Price
- ELWS N/A
- EDSA $21.00
- AVG Volume (30 Days)
- ELWS 14.0K
- EDSA 23.4K
- Earning Date
- ELWS 03-03-2025
- EDSA 05-09-2025
- Dividend Yield
- ELWS N/A
- EDSA N/A
- EPS Growth
- ELWS N/A
- EDSA N/A
- EPS
- ELWS N/A
- EDSA N/A
- Revenue
- ELWS $2,292,406.00
- EDSA N/A
- Revenue This Year
- ELWS N/A
- EDSA N/A
- Revenue Next Year
- ELWS N/A
- EDSA N/A
- P/E Ratio
- ELWS N/A
- EDSA N/A
- Revenue Growth
- ELWS 404.13
- EDSA N/A
- 52 Week Low
- ELWS $1.04
- EDSA $1.55
- 52 Week High
- ELWS $8.68
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- ELWS 43.93
- EDSA 47.13
- Support Level
- ELWS $2.00
- EDSA $2.31
- Resistance Level
- ELWS $2.34
- EDSA $2.54
- Average True Range (ATR)
- ELWS 0.26
- EDSA 0.11
- MACD
- ELWS 0.03
- EDSA -0.03
- Stochastic Oscillator
- ELWS 24.45
- EDSA 3.45
About ELWS Earlyworks Co. Ltd.
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.